GENE ONLINE|News &
Opinion
Blog

2021-06-18| ChinaPolicySpecial

From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships

by Daniel Ojeda
Share To
The US-China relationship is under a lot of stress following a trade war and a global pandemic. For companies, these are crucial markets that offer great opportunities but also great challenges.
During the BIO Digital 2021, a panel of policy experts discussed their opinions and views on how the US-China relationships will affect biotechnology companies in 2021. 

GO Prime with only $1.49 now

LATEST
Novartis Reported Two Deaths Following Zolgensma Gene Therapy
2022-08-12
Extreme Climate Change Is Aggravating Infectious Diseases!
2022-08-11
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Potential $1 billion Acquisition of TeneoTwo by AstraZeneca comes to Fruition
2022-08-11
Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease
2022-08-11
FDA Finds Carcinogen In Merck’s Diabetes Drug, Allows Continued Sales To Avoid Shortage
2022-08-11
2026: The Promise of Synthetic Biology
2022-08-11
EVENT
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-20
Cell & Gene Therapy USA 2022
Virtual
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!